Treatments

International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
Sergi Pascual Guardia, Judith Marin-Corral, Manuela Carugati, Stefano Aliberti, Oriol Sibila, Francisco Sanz, Giovanni Sotgiu, Pedro J. Marcos, Martin Kolditz, Marcos I. Restrepo

European Respiratory Journal Sep 2020, 56 (suppl 64) 4669; DOI: 10.1183/13993003.congress-2020.4669
PGE2 and PGI2 restore defective lung epithelial progenitors induced by cigarette smoke
Xinhui Wu, Sophie Bos, Lars Verkleij, Angela D’Ambrosi, Martina Schmidt, Loes Kiestemaker, Reinoud Gosens

European Respiratory Journal Sep 2020, 56 (suppl 64) 4785; DOI: 10.1183/13993003.congress-2020.4785
Changes in DNA methylation after corticosteroids treatment in COPD patients
Jos van Nijnatten, Corry-Anke Brandsma, Pieter Hiemstra, Wim Timens, Maarten Van Den Berge, Alen Faiz

European Respiratory Journal Sep 2020, 56 (suppl 64) 4783; DOI: 10.1183/13993003.congress-2020.4783
Multidisciplinary team meetings dedicated to children interstitial lung diseases (chILD) – a 2-years experience
Nadia Nathan, Alice Hadchouel, Maryem Sari Hassoun, Céline Lustremant, Delphine Habouria, Annick Clement, Ralph Epaud, . For The Respirare And Respifil Groups

European Respiratory Journal Sep 2020, 56 (suppl 64) 5292; DOI: 10.1183/13993003.congress-2020.5292
Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
Andrea Mazzaro, Mirco Ros, Silvia Bertolo, Pierluigi Ciet, Francesco Serafini, Giovanni Morana

European Respiratory Journal Sep 2020, 56 (suppl 64) 4338; DOI: 10.1183/13993003.congress-2020.4338
Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial
Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon L. F. Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker-Herceg, Kevin K. Brown

European Respiratory Journal Sep 2020, 56 (suppl 64) 4578; DOI: 10.1183/13993003.congress-2020.4578
Changes in biomarkers with nintedanib plus sildenafil in subjects with IPF by presence of emphysema in the INSTAGE trial
Eric White, Vincent Cottin, Martin Kolb, Toby M Maher, Carina Ittrich, Claudia Diefenbach, Klaus B Rohr, Manuel Quaresma, Bruno Crestani

European Respiratory Journal Sep 2020, 56 (suppl 64) 5189; DOI: 10.1183/13993003.congress-2020.5189
FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results
Renaud Tamisier, Thibaud Damy, Jean-Marc Davy, Johan Verbraecken, Sebastien Bailly, Florent Lavergne, Alain Palot, Frederic Goutorbe, Jean-Louis Pepin, Marie-Pia D'Ortho

European Respiratory Journal Sep 2020, 56 (suppl 64) 4737; DOI: 10.1183/13993003.congress-2020.4737
Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial
Gisli Jenkins, Imre Noth, Moisés Selman, Vincent Cottin, Yasuhiko Nishioka, Jin Woo Song, Antje Prasse, Eric S White, Carina Ittrich, Claudia Diefenbach, Klaus B Rohr, Susanne Stowasser, Toby M Maher

European Respiratory Journal Sep 2020, 56 (suppl 64) 5187; DOI: 10.1183/13993003.congress-2020.5187
Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial
Claudia Valenzuela, Toby M Maher, Francesco Bonella, Alberto Pesci, Stephane Jouneau, Nina M Patel, Evans R Fernández Pérez, Rainer-Georg Goeldner, Susanne Stowasser, Rozsa Schlenker-Herceg, Manuel Quaresma, Vincent Cottin

European Respiratory Journal Sep 2020, 56 (suppl 64) 4577; DOI: 10.1183/13993003.congress-2020.4577

Main menu

User menu

Search

Treatments

Pages

Contact us